Skip to content

Clinical trials

Phase 2/3 Cardiomyopathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Phase: Phase 2/3 Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20091
20151
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ARYx Therapeutics1
Gilead Sciences1
Instituto de Cardiologia do Rio Grande do Sul1
Peking Union Medical College Hospital1
Yuksek Ihtisas Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies5
Heart Failure3
Cardiomyopathy, Dilated2
Angina Pectoris1
Atrial Fibrillation1
Atrial Flutter1
Cardiomyopathy, Hypertrophic1
Cardiomyopathy, Hypertrophic, Familial1
Dyspnea1
Hypertrophy1

Trials

Showing 26 to 5 of 5. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.